<?xml version="1.0" encoding="UTF-8"?>
<p>The number of clinical trials to be conducted in sub‐Saharan Africa after the current COVID‐19 pandemic likely will grow exponentially. As of 2
 <sup>nd</sup> of June 2020, eight countries – Gambia, Nigeria, Senegal, South Africa, Sudan and Zambia – in sub‐Saharan Africa had registered 53 COVID‐19‐related clinical trials of Bacille Calmette Guerin vaccine, chloroquine, hydroxychloroquine, antiretrovirals, and Remdesivir.
 <fn id="dewb12283-note-1001">
  <label>1</label>
  <p>Clinicaltrial.gov. COVID‐19 vaccine studies. Retrieved June 6, 2020, from 
   <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?cond=COVID-19%26term=Vaccine%26cntry=%26state=%26city=%26dist" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/results?cond=COVID‐19&amp;term=Vaccine&amp;cntry=&amp;state=&amp;city=&amp;dist</ext-link>=.
  </p>
 </fn> As of May 28, 2020, 224 COVID‐19 treatment and 145 COVID‐19 vaccine research programs were underway, with some countries in sub‐Saharan Africa conducting phase 2 and/or phase 3 trials.
 <fn id="dewb12283-note-1002">
  <label>2</label>
  <p>Milken Institute. (2020). COVID‐19 treatment and vaccine tracker. Retrieved May 29, 2020, from 
   <ext-link ext-link-type="uri" xlink:href="https://milkeninstitute.org/covid-19-tracker" xmlns:xlink="http://www.w3.org/1999/xlink">https://milkeninstitute.org/covid‐19‐tracker</ext-link>; Wealth Management. (2020, 17 April). The hunt for COVID‐19 treatments and vaccines. Retrieved May 28, 2020, from 
   <ext-link ext-link-type="uri" xlink:href="https://www.rbcwealthmanagement.com/gb/en/research-insights/the-hunt-for-covid-19-treatments-and-vaccine/detail/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.rbcwealthmanagement.com/gb/en/research‐insights/the‐hunt‐for‐covid‐19‐treatments‐and‐vaccine/detail/</ext-link>.
  </p>
 </fn> Lessons learnt from the successful implementation of HIV prevention and treatment clinical trials,
 <fn id="dewb12283-note-1003">
  <label>3</label>
  <p>Baker, L‐G., &amp; Mizrahi, V. (2020). COVID‐19 research in Africa. Science. 368(6494), 919.</p>
 </fn> the successful clinical trials conducted during the West Africa Ebola epidemic,
 <fn id="dewb12283-note-1004">
  <label>4</label>
  <p>Henao‐Restrepo. A.M., Camacho, A., Longini, I.M., et al. (2017). Efficacy and effectiveness of an rVSV‐vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open‐label, cluster‐randomised trial (Ebola Ça Suffit!). Lancet. 389(10068), 504; Dunning, J., Sahr, F., Rojek, A., et al. (2016). Experimental Treatment of Ebola Virus Disease with TKM‐130803: A Single‐Arm Phase 2 Clinical Trial. PLoS Med. 13(4), e1001997. Sissoko, D., Laouenan, C., Folkesson, E., et al. ; JIKI Study Group. (2016). Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single‐arm proof‐of‐concept trial in Guinea. PLoS Med. 3, e1001967.</p>
 </fn> and the COVID‐19‐related clinical trials will likely pave the way for more clinical trials of national and regional importance.
</p>
